A dangerous pneumonia strand, with an estimated mortality rate as high as 40 percent, has spread across the nation and outside of health care facilities, according to The New York Times.
Klebsiella pneumoniae, which poses as a serious danger to older hospitalized patients, is usually treated with broad-spectrum cephalosporin antibiotics. But a study in the Infection Control and Hospital Epidemiology reports that the proportion of Klebsiella cases resistant to cephalosporins increased to 11.6 percent in 2010 from 5.3 percent in 1999.
"The problem with CRKP [fusion_builder_container hundred_percent="yes" overflow="visible"][fusion_builder_row][fusion_builder_column type="1_1" background_position="left top" background_color="" border_size="" border_color="" border_style="solid" spacing="yes" background_image="" background_repeat="no-repeat" padding="" margin_top="0px" margin_bottom="0px" class="" id="" animation_type="" animation_speed="0.3" animation_direction="left" hide_on_mobile="no" center_content="no" min_height="none"][carbapenem-resistant Klebsiella strains]," said Ramanan Laxminarayan, researcher at the Center for Disease Dynamics, Economic and Policy, "is that we don't have any new drugs." Read the full details here:
Failure to diagnose pneumonia, infections and even medication errors cause thousands of needless deaths and longer hospital stays each year in the U.S.
If you or someone you love has been injured by medical malpractice, call the professionals at Crandall & Pera Law for a free consultation.
[/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]